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Resumo
O mesotelioma maligno da pleura é o tumor 
primário da pleura mais comum e apresenta um 
prognóstico sombrio. A TC continua a ser o 
método complementar de diagnóstico de eleição 
no diagnóstico, estadiamento e seguimento 
desta patologia, embora a RM e a PET/TC com 
2-[fluorine-18]fluoro-2-deoxy-d-glucose (FDG) 
tenham surgido como estudos complementares 
importantes. Apresentamos um caso de um 
mesotelioma sarcomatóide da pleura, o tipo 
mais raro de mesotelioma, dando ênfase aos 
achados tomodensitométricos e à correlação 
anatomopatológica que permitiu chegar ao 
diagnóstico final.
Palavras-chave
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da pleura; Tomografia computadorizada.
Abstract
Malignant pleural mesothelioma is the most 
common primary tumor of  the pleura and 
carries a poor prognosis. CT remains the method 
of  choice to diagnosis, staging and follow-
up this pathology alt-hough MR imaging and 
PET/CT with 2-[fluorine-18]fluoro-2-deoxy-d-
glucose (FDG) have emerged as complementary 
studies. We present a case of  pleural sarcomatoid 
mesothelioma, the rarest type of  mesothelioma, 
with focus in thoracic CT findings and 
anatomopathological correlation that helped to 
reach the final diagnosis.
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Caso Clínico / Radiological Case Report
Introdution
Primary tumors of  the pleura are rare and among them the 
most common is the diffuse malignant mes-othelioma. Unlike 
the benign form of  focal mesothelioma, the majority of  cases 
of  malignant mesothe-lioma occur in patients with previous 
exposure to asbestos fibers, with a mean time from exposure to 
the development of  the disease of  about 40 years.1,2
Histological major types of  malignant mesothelioma are 
epithelial, sarcomatoid and biphasic types, with sacomatoid 
being the rarest (only about 10-15% of  cases3) and having the 
worst prognosis (median survival time of  6 months).4
Usually clinical findings are not specific, with dyspnea, cough 
and weight loss being the most com-mon. CT has a key role in 
the diagnosis of  the disease.
Clinical Case
An 83-year-old man without previous respiratory symptoms 
was admitted at the hospital at December 2014 for evaluation 
of  shortness of  breath and weight loss for several months. He 
is medical history is unremarkable besides previous exposure 
to asbestos fibers many years before (former carpenter).
Thoracic x-ray at admission showed right pleural effusion 
(fig.1) and CT was ordered for further eval-uation, revealing 
simple effusion with water density and no pleural thickening or 
contrast enhance-ment were seen. Lung evaluation showed no 
abnormalities (fig.2). 
Symptomatic treatment with diuretics was carried out 
and imaging follow-up six months later was de-cided, 
demonstrating emergence of  small pleural calcifications 
and persistence of  right pleural effusion (fig.3). Sequential 
CT´s revealed rapid progression of  the calcifications and 
development of  an aggres-sive soft tissue mass extending 
to the right hilum and mediastinum (fig. 4, 5 and 6). 
Transthoracic lung biopsy was performed,  showing a 
moderately cellular neoplasia of  spindle to oval cells 
arranged in trabeculae within a collagenous matrix, with 
frequent mitotic figures and the immunohistochemistry 
study revealed positivity for GLUT-1 and negative for 
Figure 1 – Initial thoracic x ray at admission on December 2014 shows 
large right pleural effusion and enlarge cardiac silhouette in a patient with 
cardiac pacemaker.
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all other markers used, namely, WT1, CK5, CK7, CD34, 
podoplanin and calretinin (fig. 7). 
Follow-up CT after 7 months, there was also rib metastasis 
but no distant metastasis (fig.8). The patient died 2 months 
later of  respiratory failure.
Figure 2 – First thoracic CT two days later. (a) Axial an d (b) coronal images show a large pleural effusion with water density and no pleural wall 
enhancement or pleural nodules. No pleural calcification is seen. Lung window didn´t show any alterations.
Figure 3 – Follow-up contrast-enhanced thoracic CT at August 2015 
(6 months after the initial examination) continue to reveal right water-
density pleural effusion and “de novo” small, coarse pleural calci-fications 
(arrowheads). There is some pleural thickening but no pleural nodules were 
seen. 
Figure 4 – Coronal non-enhanced thoracic CT at December 2015 
shows substantial growth of  the calcified mass at the mediastinal pleural 
(arrowhead), which invades and compresses the mediastinal structures. No 
pleural nodules or distant metastasis were seen. 
Figure 5 – Coronal (a) and axial (b) contrast-enhanced CT at February 2016 shows the calcified mass to continue to grow and become even more ossified, 
causing collapse of  the superior lobe of  the ipsilateral lung. The other pleural calcifications also show increase in size and number. Note also left sided small 
pleural effusion.
Discussion
Pleural malignant mesothelioma is usually diagnosed 
late in disease course and has a poor prognosis. Clinical 
presentation of  malignant mesothelioma is usually insidious 
with chest pain, dyspnea, fatigue and weight loss. At physical 
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Figure 6 – Sequencial CT images showing the rapid evolution of  the pleural cacifications (arrowheads). (a) December 2014; (b) 
July 2015; (c) December 2015; (d) February 2016. Note that in image (c) there is significant narrowing of  the right main bronchus 
and in (d) there is complete obstruction of  the bronchus with lung collapse.
Figure 7 - Histology: moderately cellular neoplasia of  spindle to oval cells arranged in trabeculae within a collagenous matrix. 
Frequent mitotic figures, apoptotic debris  and  focal areas of  chondroid diferentiation were also present.
Immunohistochemistry: the neoplastic cells were diffusely positive for GLUT-1 and negative for all other markers used, namely, 
WT1, CK5, CK7, CD34, podoplanin and calretinin.
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examination absence of  respiratory sounds at auscultation 
and clubbing can be found but are nonspecific. Laboratory 
tests may show hypogammaglobulinemia, anemia and 
thrombocytosis.3 Chest CT is the imaging modality of  choice 
to diagnose, evaluate the extent of  the disease and is often 
sufficient for staging and treatment planning. Thoracic MRI 
is not routinely used but can be useful in specific cases to 
evaluate the extent of  the disease. PET can be useful in 
distin-guishing benign from malignant pleural calcifications 
and thickening (since malignant lesions have a higher uptake 
of  FDG) and in staging of  malignant mesothelioma (with 
an emerging role in detecting mediastinal node metastases 
and occult extrathoracic disease). Combined with spatial 
resolution pro-vided by CT, PET has a promising role in 
diagnosis, staging and surgery planning of  malignant meso-
thelioma.6 
It is well recognized that the presence of  calcified pleural 
plaques is a common benign finding associ-ated with asbestos 
exposure.5 On the contrary, typical features worrisome for 
malignant mesotheli-oma are unilateral pleural effusion, 
nodular pleural thickening and interlobar fissure thickening.3,6
The presence of  coarse pleural calcification is not always 
synonym of  benign disease and radiologists must be aware 
of  the histological sarcomatoid subtype, which presents with 
depositions of  extensively and densely calcified soft tissue 
masses on the pleural layers. Unilateral, clumped, irregular, 
densely calcified pleural masses distributed fairly evenly 
throughout the substance of  the thickened pleura are also 
signs that should alert for the presence of  malignancy.7
Imaging findings in sarcomatoid malignant mesothelioma 
are similar to other malignant mesothelio-mas but with 
the presence of  coarse calcified masses in the pleura. 
It is important not to confuse the sarcomatoid type of  
mesothelioma with development of  a non-sarcomatoid 
mesothelioma that engulfs the preexisting benign calcified 
pleural plaques.7 
Histologically, sarcomatoid mesothelioma is characterized 
by absence of  epithelial elements in the biopsy material or 
<10% of  epithelial tissue and the presence of  spindle cells 
with nuclear atypia.3,4 The list of  differential diagnosis of  
sarcomatoid pleural mesothelioma includes sarcomas originat-
ing in the chest wall, lung, abdominal wall or peritoneum 
with extension to the pleura, sarcomatoid carcinoma of  the 
lung, metastases from osteosarcoma, breast, thyroid, ovary 
or thymoma and local-ized pleural mesothelioma (solitary 
fibrous tumor of  pleura).1,5,8,9,10 Primary or secondary pleural 
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involvement by a tumor of  the surrounding structures can 
be difficult to assess, being a crucial step to narrow the 
differential diagnosis list. Pulmonary neoplasms usually have 
acute angles with the chest wall, are centered in the lung, and 
engulf  the pulmonary vasculature, whereas a pleural neo-
plasm shows obtuse angles with the lateral chest wall and 
displaces the pulmonary vasculature. On the other hand 
features that helps differentiating extrapleural neoplasms 
with invasion of  the pleura from primary pleural lesions 
is that the latter do not cause erosion of  ribs and displace 
the extrapleural fat outward while extrapleural neoplasms 
displace the extrapleural fat inward.2 
Although secondary involvement of  pleura is more 
common than primary tumors, pleural metastases from 
osteogenic sarcomas are extremely rare and normally occur 
as lung metastases that migrated to the parietal pleura due to 
contact.10,11 A known history of  a primary tumor producer 
of  osteoid is an important clue to the diagnosis of  secondary 
involvement.
Solitary fibrous tumor of  the pleura (localized pleural 
mesothelioma) is an uncommon pleural tumor of  
mesenchymal origin and can be either benign or malignant. 
There are no characteristic imaging find-ings but usually it 
appears as a peripheral, smooth, well-demarcated soft-tissue-
density mass, often with a pedunculated stalk extending to 
the extending into the pleura/interlobar fissure/hilum;1,5,12 
calcifications and pleural effusion are uncommon but if  
present can complicate the differ-ential to sarcomatoid 
malignant mesothelioma. Definite differentiation from 
malignant mesothelioma is achieved by immunohistochemical 
staining, in which solitary fibrous tumor is positive for CD34, 
un-like malignant mesothelioma.5,12
Conclusion
Sarcomatoid mesothelioma is the rarest form of  malignant 
mesothelioma and is characterized by the presence of  coarse 
pleural calcifications. It is important that the radiologist is 
acquainted with this tu-mor subtype in order to include 
it in the differential diagnosis list of  malignant pleural 
calcifications and not to confound it with benign pleural 
calcified plaques.  
Figure 8 – Coronal 
(a) and axial (b) 
contrast-enhanced CT 
one month later shows 
the development of  
a soft tissue mass 
at the site of  the 
pleural calcifications 
at lung base, invading 
the ribs and direct 
diaphragmatic 
extension of  
the tumor to the 
peritoneum. Also note 
the marked thickening 
of  the contralateral 
pleura.
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